Bank Julius Baer & Co’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$390K Hold
12,000
﹤0.01% 452
2025
Q4
$422K Hold
12,000
﹤0.01% 440
2025
Q3
$315K Sell
12,000
-5,008
-29% -$149K ﹤0.01% 456
2025
Q2
$451K Buy
17,008
+9,008
+113% +$237K ﹤0.01% 394
2025
Q1
$193K Buy
8,000
+3,020
+61% +$95.4K ﹤0.01% 427
2024
Q4
$221K Buy
4,980
+345
+7% +$19.7K ﹤0.01% 416
2024
Q3
$348K Buy
+4,635
New +$272K ﹤0.01% 363
2021
Q2
Sell
-6,400
Closed -$40K 877
2021
Q1
$40K Sell
6,400
-1,593
-20% -$11.2K ﹤0.01% 689
2020
Q4
$45K Buy
7,993
+2,993
+60% +$18.1K ﹤0.01% 696
2020
Q3
$29K Hold
5,000
﹤0.01% 643
2020
Q2
$36K Sell
5,000
-1
-0% -$7 ﹤0.01% 587
2020
Q1
$23K Buy
+5,001
New +$30.7K ﹤0.01% 578

Other funds holding VKTX